Press Releases

April 21, 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness

March 31, 2008
DUSA Completes Enrollment for Phase IIb Trial of Levulan® Photodynamic Therapy for Moderate to Severe Acne

March 6, 2008
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil

March 4, 2008
DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results

March 4, 2008 Fourth Quarter and Full Year 2007 Conference Call
March 4, 2008 Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results Conference Call

February 28, 2008
DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results Conference Call

February 20, 2008
DUSA Investor Presentation at Roth Capital Partners 20th Annual Growth Stock Conference 1:00 PM (Pacific), 4:00 PM (Eastern)

February 13, 2008
DUSA Pharmaceuticals to Present at Roth Capital Partners 20th Annual Growth Stock Conference

February 6, 2008
Leading Investigators Highlight Advances in Photodynamic Therapy at the American Academy of Dermatology Annual Meeting

November 9, 2007 Quarterly Conference Call
DUSA Pharmaceuticals Third Quarter 2007 Financial Results and Corporate Highlights